L391-0918 Screening compound: N-(4-bromo-3-methylphenyl)-2-[7-(morpholin-4-yl)-4-oxo-3H,4H-pyrimido[4,5-d][1,3]diazin-3-yl]acetamide

L391-0918 Screening compound: N-(4-bromo-3-methylphenyl)-2-[7-(morpholin-4-yl)-4-oxo-3H,4H-pyrimido[4,5-d][1,3]diazin-3-yl]acetamide
L391-0918 Screening compound: N-(4-bromo-3-methylphenyl)-2-[7-(morpholin-4-yl)-4-oxo-3H,4H-pyrimido[4,5-d][1,3]diazin-3-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L391-0918
N-(4-bromo-3-methylphenyl)-2-[7-(morpholin-4-yl)-4-oxo-3H,4H-pyrimido[4,5-d][1,3]diazin-3-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L391-0918

Molecular Formula

C19H19BrN6O3 (C19 H19 BrN6 O3)

Compound Name

N-(4-bromo-3-methylphenyl)-2-[7-(morpholin-4-yl)-4-oxo-3H,4H-pyrimido[4,5-d][1,3]diazin-3-yl]acetamide

IUPAC name

N-(4-bromo-3-methylphenyl)-2-[7-(morpholin-4-yl)-4-oxo-3H4H-pyrimido[45-d][13]diazin-3-yl]acetamide

SMILES

Cc(cc(cc1)NC(CN(C=Nc2c3cnc(N4CCOCC4)n2)C3=O)=O)c1Br

InChI

InChI=1S/C19H19BrN6O3/c1-12-8-13(2-3-15(12)20)23-16(27)10-26-11-22-17-14(18(26)28)9-21-19(24-17)25-4-6-29-7-5-25/h2-3,8-9,11H,4-7,10H2,1H3,(H,23,27)

InChI Key

MNKLOSZNIDZAPX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27250656

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.3

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.967

Distribution Coefficient, logD

1.967

Water Solubility, LogSw

-2.83

Polar Surface Area

79.445

Acid Dissociation Constant (pKa)

11.32

Base Dissociation Constant (pKb)

0.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

L391-0918 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L391-0918 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L391-0918?
Check Price and Availability of L391-0918, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L391-0918 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L391-0918
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L391-0918
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L391-0918 available by request